Table of Contents
Scholarly Research Exchange
Volume 2009, Article ID 979318, 10 pages
http://dx.doi.org/10.3814/2009/979318
Review Article

Apoptosis in Human Acute Myocardial Infarction: The Rationale for Clinical Trials of Apoptosis Inhibition in Acute Myocardial Infarction

Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, BC, V5Z 1M9, Canada

Received 16 October 2008; Revised 21 December 2008; Accepted 20 January 2009

Copyright © 2009 Simon W. Rabkin. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. F. Kerr, A. H. Wyllie, and A. R. Currie, “Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics,” British Journal of Cancer, vol. 26, no. 4, pp. 239–257, 1972. View at Google Scholar
  2. L. M. Buja, “Myocardial ischemia and reperfusion injury,” Cardiovascular Pathology, vol. 14, no. 4, pp. 170–175, 2005. View at Publisher · View at Google Scholar · View at PubMed
  3. D. W. Nicholson, “Caspase structure, proteolytic substrates, and function during apoptotic cell death,” Cell Death & Differentiation, vol. 6, no. 11, pp. 1028–1042, 1999. View at Publisher · View at Google Scholar · View at PubMed
  4. R. A. Gottlieb, K. O. Burleson, R. A. Kloner, B. M. Babior, and R. L. Engler, “Reperfusion injury induces apoptosis in rabbit cardiomyocytes,” The Journal of Clinical Investigation, vol. 94, no. 4, pp. 1621–1628, 1994. View at Publisher · View at Google Scholar
  5. M. Neuss, M. T. Crow, A. Chesley, and E. G. Lakatta, “Apoptosis in cardiac disease—what is it—how does it occur,” Cardiovascular Drugs & Therapy, vol. 15, no. 6, pp. 507–523, 2001. View at Publisher · View at Google Scholar
  6. S. W. Rabkin and J. Y. Kong, “Nitroprusside induces cardiomyocyte death: interaction with hydrogen peroxide,” American Journal of Physiology, vol. 279, no. 6, pp. H3089–H3100, 2000. View at Google Scholar
  7. J. Y. Kong and S. W. Rabkin, “Palmitate-induced cardiac apoptosis is mediated through CPT-1 but not influenced by glucose and insulin,” American Journal of Physiology, vol. 282, no. 2, pp. H717–H725, 2002. View at Google Scholar
  8. C. Communal, K. Singh, D. B. Sawyer, and W. S. Colucci, “Opposing effects of β1- and β2-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein,” Circulation, vol. 100, no. 22, pp. 2210–2212, 1999. View at Google Scholar
  9. D. R. Meldrum, “Tumor necrosis factor in the heart,” American Journal of Physiology, vol. 274, no. 3, pp. R577–R595, 1998. View at Google Scholar
  10. Y. Toyoda, T. Shida, N. Wakita, N. Ozaki, R. Takahashi, and M. Okada, “Evidence of apoptosis induced by myocardial ischemia: a case of ventricular septal rupture following acute myocardial infarction,” Cardiology, vol. 90, no. 2, pp. 149–151, 1998. View at Publisher · View at Google Scholar
  11. G. Itoh, J. Tamura, M. Suzuki et al., “DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis,” American Journal of Pathology, vol. 146, no. 6, pp. 1325–1331, 1995. View at Google Scholar
  12. G. Olivetti, F. Quaini, R. Sala et al., “Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart,” Journal of Molecular and Cellular Cardiology, vol. 28, no. 9, pp. 2005–2016, 1996. View at Publisher · View at Google Scholar · View at PubMed
  13. R. H. Bardales, L. S. Hailey, S. S. Xie, R. F. Schaefer, and S.-M. Hsu, “In situ apoptosis assay for the detection of early acute myocardial infarction,” American Journal of Pathology, vol. 149, no. 3, pp. 821–829, 1996. View at Google Scholar
  14. J. P. Veinot, D. A. Gattinger, and H. Fliss, “Early apoptosis in human myocardial infarcts,” Human Pathology, vol. 28, no. 4, pp. 485–492, 1997. View at Publisher · View at Google Scholar
  15. A. Saraste, “Morphologic criteria and detection of apoptosis,” Herz, vol. 24, no. 3, pp. 189–195, 1999. View at Google Scholar
  16. T. N. James, “The variable morphological coexistence of apoptosis and necrosis in human myocardial infarction: significance for understanding its pathogenesis, clinical course, diagnosis and prognosis,” Coronary Artery Disease, vol. 9, no. 5, pp. 291–308, 1998. View at Publisher · View at Google Scholar
  17. G. Ottaviani, A. M. Lavezzi, L. Rossi, and L. Matturri, “Proliferating cell nuclear antigen (PCNA) and apoptosis in hyperacute and acute myocardial infarction,” European Journal of Histochemistry, vol. 43, no. 1, pp. 7–14, 1999. View at Google Scholar
  18. F. R. Piro, C. R. T. di Gioia, P. Callo, C. Giordano, and G. d'Amati, “Is apoptosis a diagnostic marker of acute myocardial infarction? An autopsy study comparing histologic, immunohistochemical, TUNEL, and DNA electrophoresis evidence,” Archives of Pathology & Laboratory Medicine, vol. 124, no. 6, pp. 827–831, 2000. View at Google Scholar
  19. M. S. Rodríguez-Calvo, M. N. Tourret, L. Concheiro, J. I. Muñoz, and J. M. Suárez-Peñaranda, “Detection of apoptosis in ischemic heart: usefulness in the diagnosis of early myocardial injury,” American Journal of Forensic Medicine and Pathology, vol. 22, no. 3, pp. 278–284, 2001. View at Publisher · View at Google Scholar
  20. A. Abbate, G. G. L. Biondi-Zoccai, and A. Baldi, “Myocardiocyte loss due to apoptosis,” European Heart Journal, vol. 23, no. 23, pp. 1889–1890, 2002. View at Publisher · View at Google Scholar
  21. M. Nakatome, R. Matoba, Y. Ogura et al., “Detection of cardiomyocyte apoptosis in forensic autopsy cases,” International Journal of Legal Medicine, vol. 116, no. 1, pp. 17–21, 2002. View at Publisher · View at Google Scholar
  22. A. Baldi, A. Abbate, R. Bussani et al., “Apoptosis and post-infarction left ventricular remodeling,” Journal of Molecular and Cellular Cardiology, vol. 34, no. 2, pp. 165–174, 2002. View at Publisher · View at Google Scholar · View at PubMed
  23. E. Edston, L. Gröntoft, and J. Johnsson, “TUNEL: a useful screening method in sudden cardiac death,” International Journal of Legal Medicine, vol. 116, no. 1, pp. 22–26, 2002. View at Publisher · View at Google Scholar
  24. R. Bussani, A. Abbate, G. G. L. Biondi-Zoccai et al., “Right ventricular dilatation after left ventricular acute myocardial infarction is predictive of extremely high peri-infarctual apoptosis at postmortem examination in humans,” Journal of Clinical Pathology, vol. 56, no. 9, pp. 672–676, 2003. View at Publisher · View at Google Scholar
  25. A. Abbate, G. G. L. Biondi-Zoccai, R. Bussani et al., “High-risk clinical features predict increased post-infarction myocardial apoptosis and the benefits as a result of an open infarct-related artery,” European Journal of Clinical Investigation, vol. 33, no. 8, pp. 662–668, 2003. View at Publisher · View at Google Scholar
  26. A. Abbate, G. G. L. Biondi-Zoccai, R. Bussani et al., “Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure,” Journal of the American College of Cardiology, vol. 41, no. 5, pp. 753–760, 2003. View at Publisher · View at Google Scholar
  27. G. G. L. Biondi-Zoccai, A. Abbate, F. Vasaturo et al., “Increased apoptosis in remote non-infarcted myocardium in multivessel coronary disease,” International Journal of Cardiology, vol. 94, no. 1, pp. 105–110, 2004. View at Publisher · View at Google Scholar · View at PubMed
  28. G. G. L. Biondi-Zaccai, A. Abbate, R. Bussani et al., “Reduced post-infarction myocardial apoptosis in women: a clue to their different clinical course?,” Heart, vol. 91, no. 1, pp. 99–101, 2005. View at Publisher · View at Google Scholar · View at PubMed
  29. G. G. L. Biondi-Zoccai, A. Abbate, R. Bussani et al., “Erratum in: reduced post-infarction myocardial apoptosis in women: a clue to their different clinical course?,” Heart, vol. 91, no. 3, p. 370, 2005. View at Publisher · View at Google Scholar
  30. A. Abbate, R. Bussani, G. G. L. Biondi-Zoccai et al., “Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium,” European Heart Journal, vol. 26, no. 19, pp. 2039–2045, 2005. View at Publisher · View at Google Scholar · View at PubMed
  31. Y. Akasaka, N. Morimoto, Y. Ishikawa et al., “Myocardial apoptosis associated with the expression of proinflammatory cytokines during the course of myocardial infarction,” Modern Pathology, vol. 19, no. 4, pp. 588–598, 2006. View at Publisher · View at Google Scholar · View at PubMed
  32. N. Zidar, Z. Dolenc-Stražar, J. Jeruc, and D. Štajer, “Immunohistochemical expression of activated caspase-3 in human myocardial infarction,” Virchows Archiv, vol. 448, no. 1, pp. 75–79, 2006. View at Publisher · View at Google Scholar · View at PubMed
  33. G. Sinagra, R. Bussani, A. Abbate et al., “Left ventricular diastolic filling pattern at Doppler echocardiography and apoptotic rate in fatal acute myocardial infarction,” American Journal of Cardiology, vol. 99, no. 3, pp. 307–309, 2007. View at Publisher · View at Google Scholar · View at PubMed
  34. A. Saraste, K. Pulkki, M. Kallajoki, K. Henriksen, M. Parvinen, and L.-M. Voipio-Pulkki, “Apoptosis in human acute myocardial infarction,” Circulation, vol. 95, no. 2, pp. 320–323, 1997. View at Google Scholar
  35. I. Budihardjo, H. Oliver, M. Lutter, X. Luo, and X. Wang, “Biochemical pathways of caspase activation during apoptosis,” Annual Review of Cell and Developmental Biology, vol. 15, pp. 269–290, 1999. View at Publisher · View at Google Scholar · View at PubMed
  36. B. Leber, J. Lin, and D. W. Andrews, “Embedded together: the life and death consequences of interaction of the bcl-2 family with membranes,” Apoptosis, vol. 12, no. 5, pp. 897–911, 2007. View at Publisher · View at Google Scholar · View at PubMed
  37. J. Misao, Y. Hayakawa, M. Ohno, S. Kato, T. Fujiwara, and H. Fujiwara, “Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction,” Circulation, vol. 94, no. 7, pp. 1506–1512, 1996. View at Google Scholar
  38. J. Y. Kong and S. W. Rabkin, “Lovastatin does not accentuate but is rather additive to palmitate-induced apoptosis in cardiomyocytes,” Prostaglandins Leukotrienes & Essential Fatty Acids, vol. 67, no. 5, pp. 293–302, 2002. View at Publisher · View at Google Scholar
  39. L. Hofstra, I. H. Liem, E. A. Dumont et al., “Visualisation of cell death in vivo in patients with acute myocardial infarction,” The Lancet, vol. 356, no. 9225, pp. 209–212, 2000. View at Publisher · View at Google Scholar
  40. P. W. L. Thimister, L. Hofstra, I. H. Liem et al., “In vivo detection of cell death in the area at risk in acute myocardial infarction,” The Journal of Nuclear Medicine, vol. 44, no. 3, pp. 391–396, 2003. View at Google Scholar
  41. H. W. Strauss, J. Narula, and F. G. Blankenberg, “Radioimaging to identify myocardial cell death and probably injury,” The Lancet, vol. 356, no. 9225, pp. 180–181, 2000. View at Publisher · View at Google Scholar
  42. J. De Sutter, C. Lahorte, Y. Taeymans, R. Dierckx, and G. Slegers, “Cell death in myocardial infarction,” The Lancet, vol. 356, no. 9239, pp. 1439–1440, 2000. View at Publisher · View at Google Scholar · View at PubMed
  43. C. Reutelingsperger and L. Hofstra, “Visualisation of cell death,” The Lancet, vol. 356, no. 9246, p. 2014, 2000. View at Publisher · View at Google Scholar · View at PubMed
  44. A. Flotats and I. Carrió, “Non-invasive in vivo imaging of myocardial apoptosis and necrosis,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 30, no. 4, pp. 615–630, 2003. View at Google Scholar
  45. A. Abbate, R. Bussani, G. G. L. Biondi-Zoccai et al., “Persistent infarct-related artery occlusion is associated with an increased myocardial apoptosis at postmortem examination in humans late after an acute myocardial infarction,” Circulation, vol. 106, no. 9, pp. 1051–1054, 2002. View at Publisher · View at Google Scholar
  46. T. Takahashi, P. van Dessel, J. C. Lopshire et al., “Optical mapping of the functional reentrant circuit of ventricular tachycardia in acute myocardial infarction,” Heart Rhythm, vol. 1, no. 4, pp. 451–459, 2004. View at Publisher · View at Google Scholar · View at PubMed
  47. E. J. Ciaccio, A. C. Tosti, and M. M. Scheinman, “Relationship between sinus rhythm activation and the reentrant ventricular tachycardia isthmus,” Circulation, vol. 104, no. 5, pp. 613–619, 2001. View at Publisher · View at Google Scholar
  48. G. Takemura and H. Fujiwara, “Morphological aspects of apoptosis in heart diseases,” Journal of Cellular & Molecular Medicine, vol. 10, no. 1, pp. 56–75, 2006. View at Publisher · View at Google Scholar
  49. M. Ohno, G. Takemura, A. Ohno et al., ““Apoptotic” myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: analysis by immunogold electron microscopy combined with in situ nick end-labeling,” Circulation, vol. 98, no. 14, pp. 1422–1430, 1998. View at Google Scholar
  50. M. Koda, G. Takemura, M. Kanoh et al., “Myocytes positive for in situ markers for DNA breaks in human hearts which are hypertrophic, but neither failed nor dilated: a manifestation of cardiac hypertrophy rather than failure,” Journal of Pathology, vol. 199, no. 2, pp. 229–236, 2003. View at Publisher · View at Google Scholar · View at PubMed
  51. M. Kanoh, G. Takemura, J. Misao et al., “Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair,” Circulation, vol. 99, no. 21, pp. 2757–2764, 1999. View at Google Scholar
  52. R. A. de Boer, D. J. van Veldhuisen, J. van der Wijk et al., “Additional use of immunostaining for active caspase-3 and cleaved actin and PARP fragments to detect apoptosis in patients with chronic heart failure,” Journal of Cardiac Failure, vol. 6, no. 4, pp. 330–337, 2000. View at Publisher · View at Google Scholar · View at PubMed
  53. P. Nicotera and G. Melino, “Regulation of the apoptosis-necrosis switch,” Oncogene, vol. 23, no. 16, pp. 2757–2765, 2004. View at Publisher · View at Google Scholar · View at PubMed
  54. M. C. Abraham and S. Shaham, “Death without caspases, caspases without death,” Trends in Cell Biology, vol. 14, no. 4, pp. 184–193, 2004. View at Publisher · View at Google Scholar · View at PubMed
  55. P. Anversa, “Myocyte death in the pathological heart,” Circulation Research, vol. 86, no. 2, pp. 121–124, 2000. View at Google Scholar
  56. A. Elsässer, A. M. Vogt, H. Nef et al., “Human hibernating myocardium is jeopardized by apoptotic and autophagic cell death,” Journal of the American College of Cardiology, vol. 43, no. 12, pp. 2191–2199, 2004. View at Publisher · View at Google Scholar · View at PubMed
  57. G. Condorelli, R. Roncarati, J. Ross, Jr. et al., “Heart-targeted overexpression of caspase-3 in mice increases infarct size and depresses cardiac function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 17, pp. 9977–9982, 2001. View at Publisher · View at Google Scholar · View at PubMed
  58. L. Bott-Flügel, H.-J. Weig, M. Knödler et al., “Gene transfer of the pancaspase inhibitor P35 reduces myocardial infarct size and improves cardiac function,” Journal of Molecular Medicine, vol. 83, no. 7, pp. 526–534, 2005. View at Publisher · View at Google Scholar · View at PubMed
  59. S. Frantz, A. Ducharme, D. Sawyer et al., “Targeted deletion of caspase-1 reduces early mortality and left ventricular dilatation following myocardial infarction,” Journal of Molecular and Cellular Cardiology, vol. 35, no. 6, pp. 685–694, 2003. View at Publisher · View at Google Scholar
  60. E. Hochhauser, Y. Cheporko, N. Yasovich et al., “Bax deficiency reduces infarct size and improves long-term function after myocardial infarction,” Cell Biochemistry and Biophysics, vol. 47, no. 1, pp. 11–19, 2007. View at Publisher · View at Google Scholar
  61. M. M. Mocanu, G. F. Baxter, and D. M. Yellon, “Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury,” British Journal of Pharmacology, vol. 130, no. 2, pp. 197–200, 2000. View at Publisher · View at Google Scholar · View at PubMed
  62. L. B. Balsam, T. Kofidis, and R. C. Robbins, “Caspase-3 inhibition preserves myocardial geometry and long-term function after infarction,” Journal of Surgical Research, vol. 124, no. 2, pp. 194–200, 2005. View at Publisher · View at Google Scholar · View at PubMed
  63. Y. Chandrashekhar, S. Sen, R. Anway, A. Shuros, and I. Anand, “Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction,” Journal of the American College of Cardiology, vol. 43, no. 2, pp. 295–301, 2004. View at Publisher · View at Google Scholar
  64. Z.-Q. Zhao, C. D. Morris, J. M. Budde et al., “Inhibition of myocardial apoptosis reduces infarct size and improves regional contractile dysfunction during reperfusion,” Cardiovascular Research, vol. 59, no. 1, pp. 132–142, 2003. View at Publisher · View at Google Scholar
  65. W. M. Yarbrough, R. Mukherjee, G. P. Escobar et al., “Pharmacologic inhibition of intracellular caspases after myocardial infarction attenuates left ventricular remodeling: a potentially novel pathway,” Journal of Thoracic & Cardiovascular Surgery, vol. 126, no. 6, pp. 1892–1899, 2003. View at Publisher · View at Google Scholar · View at PubMed
  66. S. Minatoguchi, T. Kariya, Y. Uno et al., “Caspase-dependent and serine protease-dependent DNA fragmentation of myocytes in the ischemia-reperfused rabbit heart: these inhibitors do not reduce infarct size,” Japanese Circulation Journal, vol. 65, no. 10, pp. 907–911, 2001. View at Publisher · View at Google Scholar
  67. P. Kovacs, I. Bak, L. Szendrei et al., “Non-specific caspase inhibition reduces infarct size and improves post-ischaemic recovery in isolated ischaemic/reperfused rat hearts,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 364, no. 6, pp. 501–507, 2001. View at Publisher · View at Google Scholar
  68. T. Okamura, T. Miura, G. Takemura et al., “Effect of caspase inhibitors on myocardial infarct size and myocyte DNA fragmentation in the ischemia-reperfused rat heart,” Cardiovascular Research, vol. 45, no. 3, pp. 642–650, 2000. View at Publisher · View at Google Scholar
  69. M. Kobara, T. Tatsumi, D. Kambayashi et al., “Effects of ACE inhibition on myocardial apoptosis in an ischemia-reperfusion rat heart model,” Journal of Cardiovascular Pharmacology, vol. 41, no. 6, pp. 880–889, 2003. View at Publisher · View at Google Scholar
  70. K. Kawai, F. Qin, J. Shite, W. Mao, S. Fukuoka, and C. Liang, “Importance of antioxidant and antiapoptotic effects of β-receptor blockers in heart failure therapy,” American Journal of Physiology, vol. 287, no. 3, pp. H1003–H1012, 2004. View at Publisher · View at Google Scholar · View at PubMed
  71. J. G. Burniston, A. Saini, L.-B. Tan, and D. F. Goldspink, “Aldosterone induces myocyte apoptosis in the heart and skeletal muscles of rats in vivo,” Journal of Molecular and Cellular Cardiology, vol. 39, no. 2, pp. 395–399, 2005. View at Publisher · View at Google Scholar · View at PubMed
  72. A. Abbate, F. N. Salloum, E. Vecile et al., “Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction,” Circulation, vol. 117, no. 20, pp. 2670–2683, 2008. View at Publisher · View at Google Scholar · View at PubMed
  73. A. Elsässer, K. Suzuki, and J. Schaper, “Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure,” Journal of Molecular and Cellular Cardiology, vol. 32, no. 5, pp. 711–724, 2000. View at Publisher · View at Google Scholar